RHOH and neoplasm: SPECT/CT imaging (NanoSPECT/CT-Plus), CEUS, USPIO-enhanced MRI, FRI with AngioSense680, tumor treatment studies with tTF-NGR, NGR-blocking experiments with blocking peptide GNGRAHA and tTF-NGR histology (H&E staining)